April 20, 2024
Human Microbiome Market

Human Microbiome Market is Estimated to Witness High Growth Owing to Increasing Focus on Developing Microbiome-Based Therapeutics

The human microbiome market comprises microorganisms that resides on the human body, including bacteria, viruses, fungi and their genetic elements. Advances in next generation sequencing techniques have enabled comprehensive profiling of human microbiome at an unprecedented resolution. The human microbiome plays a vital role in maintaining human health and any imbalance could lead to various diseases. Growing understanding about association of human microbiome with many health conditions like obesity, diabetes, cancer and neurological disorders has boosted research activities focused on developing microbiome-based therapeutics.

The Global human microbiome market Demand is estimated to be valued at US$ 4894.33 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the human microbiome market are Diageo plc, Pernod-Ricard SA, Constellation Brands Inc., Brown-Forman Corporation, Remy Cointreau SA, Marie Brizard Wine & Spirits, Lapostolle SA, and Berentzen-Gruppe AG.

Key opportunities in the market include expanding applications of microbiome therapeutics and diagnostics. Microbiome-based therapies hold promise for treating various metabolic, gastrointestinal and immune-mediated disorders. Further, human microbiome analysis finds use in non-communicable disease diagnostics, drug development and personalized nutrition. North America and Europe represent the largest markets, however Asia Pacific is expected to exhibit fastest growth owing to rising R&D investments and increasing healthcare expenditures.

Market drivers: The key market driver is the increasing focus on developing microbiome-based therapeutics. Growing understanding of role of human gut microbiota in various disease conditions has boosted R&D towards modulating gut microbiota composition for therapeutic applications. Many companies are exploring probiotic formulations and microbiota transplantation approaches for indications like obesity, diabetes, immune disorders etc. This is expected to drive significant growth in the human microbiome market during the forecast period.

PEST Analysis

Political: The increasing healthcare expenditure by the governments globally for research and development in microbiome associated areas provides scope for the human microbiome market. However, stringent regulations for approval of probiotic products may hamper its growth.

Economic: Rising disposable income and increasing awareness about health and wellness have augmented growth of functional food and supplementary products like probiotics and prebiotics thereby driving growth of human microbiome market.

Social: Growing consumer emphasis on digestive, immunity and chronic disease management through consumption of probiotic rich diet and supplements is a key factor for market growth. Additionally, increasing vegan population is augmenting demand for microbiome therapeutics.

Technological: Advancements in high throughput DNA sequencing technologies and bioinformatics have helped in understanding role of microbiota in health and diseases. Development of next generation sequencing coupled with metagenomics helps in sequencing entire genome in microbiome.

Geographical regions where market in terms of value is concentrated:

North America dominates the human microbiome market currently owing to higher awareness levels, technological advancements and presence of major players in the region. The US accounts for highest market share in North America due to rising incidence of chronic diseases and increased expenditure on healthcare research. Europe holds the second largest market share due to increasing focus on R&D activities.

Fastest growing region for the given market:

Asia Pacific region is expected to witness highest growth during the forecast period owing to increasing healthcare expenditure, rising lifestyle diseases, growing geriatric population and significant improvements in healthcare infrastructure. India and China are anticipated to drive the market in Asia Pacific region attributed to improving access to diagnostics and therapeutics. Support from government initiatives is further augmenting market growth in Asia Pacific region.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it